tiprankstipranks
Trending News
More News >
Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
US Market

Arcturus Therapeutics (ARCT) Income Statement

Compare
2,116 Followers

Arcturus Therapeutics Income Statement

Last quarter (Q3 2025), Arcturus Therapeutics's total revenue was $17.15M, a decrease of -55.81% from the same quarter last year. In Q3, Arcturus Therapeutics's net income was $-13.45M. See Arcturus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 138.39M$ 157.75M$ 205.75M$ 12.36M$ 9.54M
Gross Profit
$ 138.39M$ 157.75M$ 205.75M$ 12.36M$ -46.41M
Operating Expenses
$ 234.06M$ 235.95M$ 193.58M$ 215.21M$ 25.12M
Depreciation and Amortization
$ 3.54M$ 2.96M$ 1.53M$ 1.19M$ 882.00K
EBITDA
$ -77.40M$ -24.16M$ 13.70M$ -201.66M$ -70.64M
Operating Income
$ -95.67M$ -78.20M$ 12.18M$ -202.85M$ -71.52M
Other Income/Expenses
$ 14.72M$ 50.31M$ -1.53M$ -822.00K$ -624.00K
Pretax Income
$ -80.94M$ -27.89M$ 10.64M$ -203.67M$ -72.15M
Net Income
$ -80.94M$ -29.73M$ 9.35M$ -203.67M$ -72.15M
Per Share Metrics
Basic EPS
$ -3.00$ -1.12$ 0.35$ -7.74$ -3.55
Diluted EPS
$ -3.00$ -1.12$ 0.35$ -7.74$ -3.55
Weighted Average Shares Outstanding
27.00M 26.63M 26.45M 26.32M 20.30M
Weighted Average Shares Outstanding (Diluted)
27.00M 26.63M 27.09M 26.32M 20.30M
Currency in USD

Arcturus Therapeutics Earnings and Revenue History